Feiba NF


Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 21.0%
Retroperitoneal Haemorrhage 11.1%
Factor Viii Inhibition 8.6%
Haemorrhage 8.6%
Prophylaxis 7.4%
Acquired Haemophilia 3.7%
Drug Use For Unknown Indication 3.7%
Factor Viii Deficiency 3.7%
Haemorrhage Prophylaxis 3.7%
Hemophilia 3.7%
Hiv Test Positive 3.7%
Bleeding 2.5%
Bleeding Postpartum 2.5%
Bronchitis 2.5%
Haemophilia B With Anti Factor Ix 2.5%
Hemophilic Arthropathy 2.5%
Off Label Use 2.5%
Pain 2.5%
Subdural Haematoma 2.5%
Blood Disorder 1.2%
Haemorrhage 14.3%
Hepatitis B Surface Antibody Positive 10.7%
Drug Ineffective 7.1%
Factor Viii Inhibition 7.1%
Sepsis 7.1%
Haemarthrosis 3.6%
Haemorrhagic Diathesis 3.6%
Hypersensitivity 3.6%
Implant Site Thrombosis 3.6%
Ischaemic Stroke 3.6%
Mood Swings 3.6%
Post Procedural Haematoma 3.6%
Product Reconstitution Issue 3.6%
Pulmonary Embolism 3.6%
Pyrexia 3.6%
Reading Disorder 3.6%
Secretion Discharge 3.6%
Shock Haemorrhagic 3.6%
Therapeutic Response Decreased 3.6%
Throat Irritation 3.6%
Secondary
Factor Viii Inhibition 17.9%
Prophylaxis 17.9%
Bleeding 17.5%
Hemophilia 17.4%
Pain In Knee 17.3%
Haemorrhage 2.6%
Product Used For Unknown Indication 2.1%
Haemophilia B With Anti Factor Ix 2.0%
Bronchitis 1.8%
Retroperitoneal Haemorrhage 1.4%
Acquired Haemophilia 0.4%
Hiv Test Positive 0.3%
Off Label Use 0.3%
Factor Viii Deficiency 0.2%
Factor X Deficiency 0.2%
Hemophilia A 0.2%
Hemophilic Arthropathy 0.2%
Intestinal Haemorrhage 0.2%
Subdural Haematoma 0.2%
Chronic Hepatitis C 0.1%
Hepatitis B Surface Antibody Positive 84.6%
Sepsis 7.9%
Chills 0.9%
Factor Viii Inhibition 0.9%
Mood Swings 0.9%
Pulmonary Embolism 0.9%
Throat Irritation 0.9%
Haemarthrosis 0.4%
Haemorrhage 0.4%
Hypersensitivity 0.4%
Reading Disorder 0.4%
Secretion Discharge 0.4%
Therapeutic Response Decreased 0.4%
Treatment Noncompliance 0.4%

Drug Data